Patents by Inventor Kristine Salazar

Kristine Salazar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS FOR DETECTION OF ZIKA VIRAL INFECTIONS
    Publication number: 20210164061
    Abstract: Applicant discloses herein kits for identifying the presence of Zika virus in a sample. In embodiments, these kits comprise reagents disclosed herein. Applicant further provides kits for use in detecting ZIKV in a sample, the kits comprising reagents disclosed herein. In embodiments, kits include primers directed to Zika virus (ZIKV) nucleic acid sequences, the primers capable of hybridizing to ZIKV nucleic acids and to copies of ZIKV nucleic acids (including to cDNA copies of ZIKV nucleic acids). Applicant discloses herein reagents for detecting Zika virus (ZIKV) in a sample, the reagents including one or more nucleic acid primers that are capable of hybridizing to a ZIKV nucleic acid (including to cDNA copies of ZIKV nucleic acids).
    Type: Application
    Filed: August 7, 2020
    Publication date: June 3, 2021
    Inventors: Chandan Shee, Jerzy Majka, Bernardo Araujo, Ushati Das Chakravarty, Katrina Sullivan-Bibee, Jerald Sapida, Kristine Salazar
  • Methods and compositions for detection of Zika viral infections
    Patent number: 10745766
    Abstract: Applicant discloses herein kits for identifying the presence of Zika virus in a sample. In embodiments, these kits comprise reagents disclosed herein. Applicant further provides kits for use in detecting ZIKV in a sample, the kits comprising reagents disclosed herein. In embodiments, kits include primers directed to Zika virus (ZIKV) nucleic acid sequences, the primers capable of hybridizing to ZIKV nucleic acids and to copies of ZIKV nucleic acids (including to cDNA copies of ZIKV nucleic acids). Applicant discloses herein reagents for detecting Zika virus (ZIKV) in a sample, the reagents including one or more nucleic acid primers that are capable of hybridizing to a ZIKV nucleic acid (including to cDNA copies of ZIKV nucleic acids).
    Type: Grant
    Filed: April 25, 2019
    Date of Patent: August 18, 2020
    Assignee: Labrador Diagnostics LLC
    Inventors: Chandan Shee, Jerzy Majka, Bernardo Araujo, Ushati Das Chakravarty, Katrina Sullivan-Bibee, Jerald Sapida, Kristine Salazar
  • METHODS AND COMPOSITIONS FOR DETECTION OF ZIKA VIRAL INFECTIONS
    Publication number: 20190316214
    Abstract: Applicant discloses herein kits for identifying the presence of Zika virus in a sample. In embodiments, these kits comprise reagents disclosed herein. Applicant further provides kits for use in detecting ZIKV in a sample, the kits comprising reagents disclosed herein. In embodiments, kits include primers directed to Zika virus (ZIKV) nucleic acid sequences, the primers capable of hybridizing to ZIKV nucleic acids and to copies of ZIKV nucleic acids (including to cDNA copies of ZIKV nucleic acids). Applicant discloses herein reagents for detecting Zika virus (ZIKV) in a sample, the reagents including one or more nucleic acid primers that are capable of hybridizing to a ZIKV nucleic acid (including to cDNA copies of ZIKV nucleic acids).
    Type: Application
    Filed: April 25, 2019
    Publication date: October 17, 2019
    Inventors: Chandan Shee, Jerzy Majka, Bernardo Araujo, Ushati Das Chakravarty, Katrina Sullivan-Bibee, Jerald Sapida, Kristine Salazar
  • Methods and compositions for detection of Zika viral infections
    Patent number: 10301689
    Abstract: Applicant discloses herein kits for identifying the presence of Zika virus in a sample. In embodiments, these kits comprise reagents disclosed herein. Applicant further provides kits for use in detecting ZIKV in a sample, the kits comprising reagents disclosed herein. In embodiments, kits include primers directed to Zika virus (ZIKV) nucleic acid sequences, the primers capable of hybridizing to ZIKV nucleic acids and to copies of ZIKV nucleic acids (including to cDNA copies of ZIKV nucleic acids). Applicant discloses herein reagents for detecting Zika virus (ZIKV) in a sample, the reagents including one or more nucleic acid primers that are capable of hybridizing to a ZIKV nucleic acid (including to cDNA copies of ZIKV nucleic acids).
    Type: Grant
    Filed: July 31, 2017
    Date of Patent: May 28, 2019
    Assignee: Theranos IP Company, LLC
    Inventors: Chandan Shee, Jerzy Majka, Bernardo Araujo, Ushati Das Chakravarty, Katrina Sullivan-Bibee, Jerald Sapida, Kristine Salazar